BC-3195 is under clinical development by BioCity Biopharma and currently in Phase I for Metastatic Ovarian Cancer.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

To our knowledge, there are no published clinical data on DW-MRI assessment of chemotherapy response in ovarian cancer, or on the effect of previous treatment on ADC values. The multifocality and ...

Signal intensity depends on distance of target focus from receptor camera The use of imaging to evaluate peritoneal disease in ovarian cancer is essential for patient stratification to receive ...

There is a significant overlap between some symptoms of ovarian cancer, irritable bowel syndrome (IBS) and premenstrual ...

The top 5 ovarian cancer articles of 2024 covered topics such as the impact of air pollution on ovarian cancer risk, treatment strategies for patients with liver metastases, and the benefits of early ...

Ovarian cancer cells exploit cell competition by altering Flower protein isoforms in stromal cells, promoting tumor survival ...

Discover crucial early warning signs of ovarian cancer that may surface during or after meals. Learn about symptoms, risk ...